120 related articles for article (PubMed ID: 12744625)
1. Flexibility in the administration schedule of varicella vaccination in healthy adolescents and young adults.
Kosuwon P; Wasi C; Sutra S; Kositanont U; Hutagalung Y; Bock HL
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):241-5. PubMed ID: 12744625
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
Ozaki T
Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
4. Reactogenicity and immunogenicity of a varicella vaccine in healthy seronegative and seropositive subjects.
Barzaga NG; Florese RH; Bock HL
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):259-67. PubMed ID: 12236423
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group.
Kuter BJ; Ngai A; Patterson CM; Staehle BO; Cho I; Matthews H; Provost PJ; White CJ
Vaccine; 1995 Aug; 13(11):967-72. PubMed ID: 8525689
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
[TBL] [Abstract][Full Text] [Related]
8. Advantage of a two-dose versus one-dose varicella vaccine in healthy non-immune teenagers and young adults.
Kosuwon P; Sutra S; Kosalaraksa P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):697-701. PubMed ID: 15689090
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study.
Huang L; Chen Z; Song Y; Tan J; Jia N; You W; Yuan H; Feng G; Li C; Luan C; Quan Y; Wang Y
Vaccine; 2024 Jan; 42(2):396-401. PubMed ID: 38057208
[TBL] [Abstract][Full Text] [Related]
10. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.
Dubey AP; Faridi MMA; Mitra M; Kaur IR; Dabas A; Choudhury J; Mukherjee M; Mishra D
Hum Vaccin Immunother; 2017 Sep; 13(9):2032-2037. PubMed ID: 28509605
[TBL] [Abstract][Full Text] [Related]
14. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of different schedules of 2-dose varicella vaccination in China.
Deng X; Xu W; Yan R; Chen H; Shen W; Zhang M; Wu T; Xu B; He H; Ma Y
Hum Vaccin Immunother; 2016 Dec; 12(12):3113-3117. PubMed ID: 27455445
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
[TBL] [Abstract][Full Text] [Related]
19. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
[TBL] [Abstract][Full Text] [Related]
20. Immunization of healthy adults with live attenuated varicella vaccine.
Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
